MedTrace Logo

Using Health-related Quality of Life (HRQL) in Routine Clinical Care

NCT00457301 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 213

Last updated 2020-04-01

Study results available
· View outcomes & findings →

Summary

The objective of this study is to assess the effects of using HRQL measures in the clinical care of pre- and post-lung transplant patients.

The hypotheses are that the inclusion of HRQL measures, the Health Utilities Index System Mark 2(HUI2) and Mark 3 (HUI3), in routine clinical care of pre- and post-lung transplant patients, will: 1) improve patient-clinician communication;2) affect patient management; 3) improve patients' HRQL.

Conditions

Interventions

BEHAVIORAL

HUI score card

Patients completed the HUI2 and HUI3 before the encounter with the clinician, the result was graphically represented in the HUI score card. Clinicians used the HUI score card as an extra tool to help them in the management of the patients

Sponsors & Collaborators

  • Institute of Health Economics, Canada

    collaborator OTHER

  • Roche Pharma AG

    collaborator INDUSTRY

  • University of Alberta

    lead OTHER

Principal Investigators

  • David H Feeny, PhD · Professor Economics, University of Alberta

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-07-31
Primary Completion
2007-04-30
Completion
2008-05-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00457301 on ClinicalTrials.gov